Vertaling van "products or substances used " (Nederlands → Frans) :

narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September
narcotics and concerning risk limitation and therapeutic advice and of 22 January 1998 governing certain psychotropic substances and concerning risk limitation and therapeutic advice and of 12 April 1974 containing certain provisions relating to substances with hormonal, antihormonal, anabolic, beta-adrenergic, anti-infectious, antiparasitic and anti-inflammatory action Law of 15 July 1985 on the use in animals of substances with hormonal, anti-hormonal, beta-adrenergic or production stimulating action Law of 13 June 1986 on the removal and transplanting of organs, with regard to cells and tissues Law of 28 August 1991 on the practice of veterinary medicine, regarding the provision of medicines to animal carers Law of 5 July 1994 on blood and blood derivatives of human origin Law of 7 May 2004 on experiments on the human person Royal decree of 31 May 1885 approving new instructions for physicians, pharmacists and druggists Royal decree of 22 September 1966 on the conditions and arrangements for the recognition of laboratories for the analysis and checking of medicines Royal decree of 6 June 1960 on the production, preparation and wholesale distribution and delivery of medicines Royal decree no. 78 of 10 November 1967 on the practice of the healthcare professions regarding the dispensing of medicines to the public and Royal decree of 25 September

In deze gecentraliseerde procedure is een belangrijke taak weggelegd voor de Europese Autoriteit voor Voedselveiligheid (EFSA), en meer bepaald voor het FEEDAP-Panel on additives and products or substances used in animal feed (WEB) dat instaat voor de wetenschappelijke beoordeling van nieuwe additieven (risico-evaluatie).
Cette procédure centralisée prévoit un rôle important pour L’Autorité Européenne de Sécurité des Aliments (EFSA), et plus précisément pour le panel FEEDAP - Groupe scientifique sur les additifs et produits ou substances utilisés en alimentation animale) (WEB), chargé de l’évaluation scientifique des nouveaux additifs (évaluation des risques).

Herbal medicinal products In line with the provisions of the royal decree of 14 December 2006, three procedures are used for the issue of the MA or registration for herbal medicinal products: the full procedure, the “Well Established Use” procedure and a third specific procedure for traditional herbal medicines as stipulated in article 43 of the royal decree.
Herbal medicinal products In line with the provisions of the royal decree of 14 December 2006, three procedures are used for the issue of the MA or registration for herbal medicinal products: the full procedure, the “Well Established Use” procedure and a third specific procedure for traditional herbal medicines as stipulated in article 43 of the royal decree.

The prevention of adverse effects and adverse events attributable to the use of medicines and health products is closely linked with information for healthcare professionals and the public regarding the risks associated with the use of medicines and health products.
The prevention of adverse effects and adverse events attributable to the use of medicines and health products is closely linked with information for healthcare professionals and the public regarding the risks associated with the use of medicines and health products.

Advies van 21/09/2012 (PDF, 158.49 Kb) met betrekking tot " ethanol content in medicinal products used in children (including herbal medicinal products and homeopathic medicinal products)" (English version).
Avis du 21/09/2012 (PDF, 158.49 Kb) concernant l'" ethanol content in medicinal products used in children (including herbal medicinal products and homeopathic medicinal products )" (english version).

There are also age-related differences with respect to the form that the depression may take: children and young people more frequently express depression than adults, both through their schooling (frequency of attendance and results), and their behaviour (violence, alcohol consumption, use of psychotropic substances).
Des différences existent également dans la forme que peut revêtir la dépression, en fonction de l’âge: les enfants et les jeunes manifestent davantage que les adultes leur dépression, que ce soit au travers de leur scolarité (fréquentation et résultats), ou dans leur comportement (violence, consommation d’alcool et de substances psychotropes).

Set up in partnership with other ministers evidence-based education programmes addressing suicide, depression, alcohol and other substance use disorders for young people at schools and universities and involve role models and young people in the making of campaigns. viii.
For families at risk, provide home-based educational interventions to help proactively to improve parenting skills, health behaviour and interaction between parents and children. vii. Set up in partnership with other ministers evidence-based education programmes addressing suicide, depression, alcohol and other substance use disorders for young people at schools and universities and involve role models and young people in the making of campaigns. viii.

Healthcare professionals and consumers of medicines and health products need to be made aware of the utility and obligation (in the case of materiovigilance and haemovigilance) of reporting adverse effects and adverse events associated with the use of medicines and health products to the FAMHP. Furthermore, the report form should be made easy to complete
Healthcare professionals and consumers of medicines and health products need to be made aware of the utility and obligation (in the case of materiovigilance and haemovigilance) of reporting adverse effects and adverse events associated with the use of medicines and health products to the FAMHP. Furthermore, the report form should be made easy to complete

Thanks to the introduction of a proactive vigilance policy within the FAMHP via the PROACTIVE VIGILANCE spearhead, the safety profile of medicines and health products will be better known, thereby also promoting safer use of these products.
Thanks to the introduction of a proactive vigilance policy within the FAMHP via the PROACTIVE VIGILANCE spearhead, the safety profile of medicines and health products will be better known, thereby also promoting safer use of these products.

The safety and efficacy of medicines and health products are closely associated with the correct use of these products.
The safety and efficacy of medicines and health products are closely associated with the correct use of these products.